Q3 2019 Evofem Biosciences Inc Earnings Call Transcript
Good morning and thank you for joining the Evofem Q3 financial results call. I will now turn the call over to Amy Raskopf.
Thank you, Crystal. This is Amy Raskopf, Evofem Biosciences' Head of Investor Relations. Thank you for participating in today's call. If you haven't done so already, I encourage you to access the Q3 2019 presentation and the press release we issued after market yesterday, both of which are at Evofem.com under the Investors tab.
During this call management will make forward-looking statements regarding the Company's future expectations, plans and prospects that constitute forward-looking statements for the purposes of the Safe Harbor provision under the Private Securities Litigation Reform Act of 1995.
Actual results may differ materially from those expressed in or implied by these forward-looking statements as a result of various important factors, including those noted on slide 2 and described in the Company's SEC filings which are available at SEC.gov and in the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |